Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Vart

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2024
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control studyPim Bouwmans, S Reshwan K Malahe, A Lianne Messchendorp, et al.
The Lancet. Diabetes & Endocrinology|December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trialsPeter Rossing, Silvio E Inzucchi, Priya Vart, et al.
Lancet (London, England)|July 7, 2026
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trialOlivier van Minnen, Annemieke Oude Lansink-Hartgring, Rombout B E van Amstel, et al.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
American Heart Journal|June 9, 2020
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection DiseaseD H Frank Gommans, Joris Nas, Sara-Joan Pinto-Sietsma, et al.
Nature Medicine|May 5, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individualsBrendon L Neuen, Rupert W Major, Morgan E Grams, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2024
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control studyPim Bouwmans, S Reshwan K Malahe, A Lianne Messchendorp, et al.
The Lancet. Diabetes & Endocrinology|December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trialsPeter Rossing, Silvio E Inzucchi, Priya Vart, et al.
Lancet (London, England)|July 7, 2026
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trialOlivier van Minnen, Annemieke Oude Lansink-Hartgring, Rombout B E van Amstel, et al.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
American Heart Journal|June 9, 2020
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection DiseaseD H Frank Gommans, Joris Nas, Sara-Joan Pinto-Sietsma, et al.
Nature Medicine|May 5, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individualsBrendon L Neuen, Rupert W Major, Morgan E Grams, et al.
Pageof 13